Physician profile
Jackson Goldberg
NPI 1598324188
$4,091.81
in general payments reported to CMS, 2019-2025
18 companies · $2,052 in 2025
The $2,052 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $31.18 · 2023: $459 · 2024: $1,550 · 2025: $2,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,060.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $722.71 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $645.71 | 2023-2025 | Stellaris, Miebo, Xiidra |
| Abbvie INC. | $502.78 | 2024-2025 | |
| Alcon Vision LLC | $493.38 | 2023-2025 | Hydrus Microstent, Centurion, Clareon |
| Johnson & Johnson Surgical Vision, INC. | $268.73 | 2024-2025 | Tecnis Iol, Tecnis Iol |
| Harrow Eye, LLC | $255.54 | 2024-2025 | Vevye, Triesence, Iheezo |
| Glaukos Corporation | $253.63 | 2023-2025 | Idosetr |
| Sight Sciences, INC. | $187.25 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Sun Pharmaceutical Industries INC. | $170.12 | 2024 | |
| New World Medical,INC. | $142.98 | 2025 | Ahmed Glaucoma Valve, Streamline, Clearpath |
| Astellas Pharma US INC | $86.34 | 2024-2025 | Izervay |
| Dompe US, INC. | $77.80 | 2024-2025 | Oxervate |
| Coopervision INC. | $56.02 | 2024-2025 | Myday Contact Lens |
| Oculus Surgical INC. | $48.71 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $41.59 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $39.79 | 2023-2024 | Vabysmo |
| Ani Pharmaceuticals, INC. | $38.79 | 2024 | Purified Cortrophin Gel |
| Regeneron Healthcare Solutions, INC. | $28.76 | 2024 | Eylea Hd, Eylea |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackson Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.